Tourmaline Bio Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-12-31
|
-0.30
|
0.00
|
0.30
|
100.00%
|
|
2023-09-30
|
-0.60
|
0.00
|
0.60
|
100.00%
|
|
2023-06-30
|
-0.20
|
-3.49
|
-3.29
|
-1647.35%
|
|
2023-03-31
|
-0.46
|
-0.37
|
0.09
|
18.68%
|
|
2022-12-31
|
-0.49
|
-5.20
|
-4.71
|
-961.22%
|
|
2022-09-30
|
-0.45
|
-4.60
|
-4.15
|
-913.22%
|
|
2022-06-30
|
-0.46
|
-4.40
|
-3.95
|
-867.03%
|
|
2022-03-31
|
-0.38
|
-4.50
|
-4.12
|
-1074.02%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-12-31
|
-3.86
|
|
2022-12-31
|
-18.70
|
|
2021-12-31
|
-23.80
|
|
2020-12-31
|
-0.16
|